SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654151-24-000012
Filing Date
2024-04-25
Accepted
2024-04-25 07:10:00
Documents
19
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A dcph-20240425.htm   iXBRL DEF 14A 1229469
6 dcph-20240425_g1.jpg GRAPHIC 168859
7 dcph-20240425_g2.jpg GRAPHIC 17394
8 dcph-20240425_g3.jpg GRAPHIC 160882
9 dcph-20240425_g4.jpg GRAPHIC 131809
10 dcph-20240425_g5.jpg GRAPHIC 104018
  Complete submission text file 0001654151-24-000012.txt   3470005

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dcph-20240425.xsd EX-101.SCH 3399
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dcph-20240425_def.xml EX-101.DEF 4377
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dcph-20240425_lab.xml EX-101.LAB 5860
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dcph-20240425_pre.xml EX-101.PRE 3382
22 EXTRACTED XBRL INSTANCE DOCUMENT dcph-20240425_htm.xml XML 180600
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38219 | Film No.: 24872883
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)